Exposure to acellular blood products and risk of HIV infection in hemophiliacs from Belo Horizonte, Brazil
Open Access
- 1 June 1992
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 34 (3) , 227-232
- https://doi.org/10.1590/s0036-46651992000300008
Abstract
Results of a HIV prevalence study conducted in hemophiliacs from Belo Horizonte, Brazil are presented. History of exposure to acellular blood components was determined for the five year period prior to entry in the study, which occurred during 1986 and 1987. Patients with coagulations disorders (hemophilia A = 132, hemophilia B = 16 and coagulation disorders other than hemophilia = 16) were transfused with liquid cryoprecipitate, locally produced, lyophilized cryoprecipitate, imported from São Paulo (Brazil) and factor VIII and IX, imported from Rio de Janeiro (Brazil), Europe, and United States. Thirty six (22%) tested HIV seropositive. The univariate and multivariate analysis (logistic model) demonstrated that the risk of HIV infection during the study period was associated with the total units of acellular blood components transfused. In addition, the proportional contribution of the individual components to the total acellular units transfused, namely a increase in factor VIII/IX and lyophilized cryoprecipitate proportions, were found to be associated with HIV seropositivity. This analysis suggest that not only the total amount of units was an important determinant of HIV infection, but that the risk was also associated with the specific component of blood transfusedKeywords
This publication has 8 references indexed in Scilit:
- Factors Associated with AIDS and AIDS-Like Syndrome among Homosexual and Bisexual Men in Minas Gerais, BrazilInternational Journal of Epidemiology, 1990
- AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlationsBlood, 1986
- Acquisition of Antibody to Lymphadenopathy-Associated Virus in Patients with Classic Hemophilia (Factor VIII Deficiency)Annals of Internal Medicine, 1985
- Coincidental Appearance of LAV/HTLV-III Antibodies in Hemophiliacs and the Onset of the AIDS EpidemicNew England Journal of Medicine, 1985
- DIFFERENTIAL PREVALENCE OF ANTIBODY TO AIDS-ASSOCIATED RETROVIRUS IN HAEMOPHILIACS TREATED WITH FACTOR VIII CONCENTRATE VERSUS CRYOPRECIPITATE: RECOVERY OF INFECTIOUS VIRUSThe Lancet, 1985
- HTLV-III SEROPOSITIVITY IN EUROPEAN HAEMOPHILIACS EXPOSED TO FACTOR VIII CONCENTRATE IMPORTED FROM THE USAThe Lancet, 1984
- ANTIBODY TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN HAEMOPHILIACS WITH AND WITHOUT AIDSThe Lancet, 1984
- AIDSand Preventive Treatment in HemophiliaNew England Journal of Medicine, 1983